Načítá se...
Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis
BACKGROUND AND AIMS: Recent adult evidence suggests that infliximab (IFX) trough levels (TL) in patients with severe ulcerative colitis (UC) may be decreased. The aims of our study were to compare post-induction IFX TL of children with severe versus moderate UC and to evaluate short- and long-term o...
Uloženo v:
| Vydáno v: | United European Gastroenterol J |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7226697/ https://ncbi.nlm.nih.gov/pubmed/32213038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620912877 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|